0
0
11/27/22 at 1:21pm
Organization
Mja.com.au
35 words
0
Comments
Oestrogen We need to identify an ideal dosing regimen that balances neuroprotective benefits and risk of side effects, write Caitlin Finney, Artur Shvetcov and David Brown
You are the first to view
https://insightplus.mja.com.au/2022/46/oestrogens-a-novel-therapy-for-neurodegenerative-conditions/
Create an account
or login to join the discussion